RxDoctor Payments DataLook up a doctor →

Naznin Dixit

Pediatric Endocrinology · Jackson, MSNPI 1972515930

Payments from drug & device makers

$386,159in general payments, 2019–2025

Across 951 payments — averaging $406.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$164K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$72K
  • Novo Nordisk AS$69K
  • Ascendis Pharma Endocrinology Inc$33K
  • Eli Lilly$23K
  • Astrazeneca UK Limited$14K
  • plus $11K from 33 others
$2,287in research payments, 2019–2025

Across 5 payments — averaging $457.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few pediatric endocrinology providers in Mississippito place this figure against a meaningful peer group, so we don't.

Other pediatric endocrinology in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →